Seth Klarman’s portfolio: Baupost Group 13F holdings

Quarterly SEC 13F-HR filingsCIK 0001061768Latest: Q2 2026

Q3 2016 filing in brief

In its Q3 2016 13F, filed November 14, 2016, Baupost Group reported $7.0B across 44 US positions. The largest: LNG (17.3%), VSAT (12.2%), SYF (7.0%), ALLERGAN PLC (6.5%), AR (5.6%). In the quarter it opened 12 positions, sold out of 7, added to 3 and trimmed 6; positions opened and sold out came to 43.3% of the portfolio's value.

Methodology

Holdings come from the manager’s Form 13F-HR filings on SEC EDGAR, with amendments applied. Values and shares are reported at quarter-end; the filing date is when the report became public. These disclosures show reported long positions and listed options, not the manager’s entire portfolio or its trades since quarter-end.

Quarterly changes compare shares with the immediately preceding quarter on file. New and exited positions appear or disappear; added and trimmed positions change their share count by more than 1%. A share change can also reflect a stock split or other corporate action.

Opened and sold out is the value of new positions plus the prior value of exited positions, divided by the average of the two quarters’ reported portfolio values. It excludes changes to positions still held. Reported value growth includes price changes and is not a measure of investment performance. Largest-five and largest-ten weights exclude options.

Holdings

Filed Nov 14, 2016

  • 12 New
  • 3 Added
  • 6 Trimmed
  • 7 Exited

44 positions at September 30, 2016. Q/Q change compares shares with the preceding quarter.

RowTickerIssuerStatus
1LNGCHENIERE ENERGY INC$1.2B27.8M17.25%−6.7%Trimmed
2VSATVIASAT INC$861M11.5M12.24%0.0%Held
3SYFSYNCHRONY FINL$492M17.6M6.99%—New
4—ALLERGAN PLC$461M2.0M6.55%0.0%Held
5ARANTERO RES CORP$391M14.5M5.56%0.0%Held
6PBFPBF ENERGY INC$356M15.7M5.06%+47.8%Added
7—DELL TECHNOLOGIES INC$318M6.7M4.52%—New
8—TWENTY FIRST CENTY FOX INC$309M12.7M4.39%+65.6%Added
9—THERAVANCE BIOPHARMA INC$266M7.4M3.79%0.0%Held
10PYPLPAYPAL HLDGS INC$205M5.0M2.91%−11.7%Trimmed
11—TWENTY FIRST CENTY FOX INC$180M7.3M2.56%0.0%Held
12INVAINNOVIVA INC$164M14.9M2.33%−15.2%Trimmed
13VRTVEURVERITIV CORP$153M3.0M2.17%0.0%Held
14—KERYX BIOPHARMACEUTICALS INC$137M25.8M1.95%0.0%Held
15—NORTHSTAR ASSET MGMT GROUP I$128M9.9M1.82%—New
16OLNOLIN CORP$127M6.2M1.80%−42.4%Trimmed
17VMWEURVMWARE INC$118M1.6M1.67%−28.8%Trimmed
18ATRAGBXATARA BIOTHERAPEUTICS INC$115M5.4M1.63%0.0%Held
19—FORWARD PHARMA A/S$113M5.4M1.60%0.0%Held
20—LIBERTY INTERACTIVE CORP$98M2.5M1.40%0.0%Held
21—COLONY CAP INC$81M4.4M1.15%—New
22—CHIPMOS TECH BERMUDA LTD$74M3.8M1.06%0.0%Held
23—NORTHSTAR RLTY FIN CORP$72M5.5M1.03%—New
24—KLX INC$70M2.0M1.00%0.0%Held
25—SILVER RUN ACQUISITION CORP$59M3.8M0.84%0.0%Held
26—AMERICAN INTL GROUP INC$55M2.6M0.78%+1.7%Added
27NGNOVAGOLD RES INC$53M9.5M0.76%0.0%Held
28BATRKLIBERTY MEDIA CORP DELAWARE$52M3.0M0.74%0.0%Held
29ODPEUROFFICE DEPOT INC$46M13.0M0.66%—New
30—CASCADIAN THERAPEUTICS INC$41M25.0M0.58%0.0%Held
31INVA 2.125 01/15/23THERAVANCE INC$41M48.2M0.58%0.0%Held
32—CONYERS PK ACQUISITION$37M3.7M0.53%—New
33PRTKEURPARATEK PHARMACEUTICALS INC$27M2.0M0.38%0.0%Held
34—SABAN CAP ACQUISITION CORP$23M2.3M0.33%—New
35CACCCREDIT ACCEP CORP MICH$20M100.0K0.29%0.0%Held
36RUNSUNRUN INC$18M2.8M0.26%0.0%Held
37KIN1USDKINDRED BIOSCIENCES INC$15M3.0M0.21%−0.1%Held
38BATRALIBERTY MEDIA CORP DELAWARE$14M800.0K0.20%0.0%Held
39—OREXIGEN THERAPEUTICS INC$7M2.2M0.11%—New
40—TOBIRA THERAPEUTICS INC$6M160.8K0.09%—New
41TMQTRILOGY METALS INC NEW$6M10.6M0.08%—New
42—CITIGROUP INC$5M102.6M0.08%0.0%Held
43—SILVER RUN ACQUISITION CORP$5M950.0K0.07%−24.0%Trimmed
44—CONYERS PK ACQUISITION$1M1.2M0.02%—New
7 exited positions

Positions held in the preceding quarter and absent from this filing. Values and shares are from the preceding quarter.

TickerIssuerPrevious valuePrevious shares
—E M C CORP MASS$1.5B57.0M
CCITIGROUP INC$219M5.2M
CARAVIS BUDGET GROUP$58M1.8M
—SUNEDISON SEMICONDUCTOR LTD$50M8.4M
—OCH ZIFF CAP MGMT GROUP$13M3.4M
—OREXIGEN THERAPEUTICS INC$10M22.3M
—NOVACOPPER INC$5M10.6M
Every quarter on file (53)

From the manager’s Form 13F-HR filings on SEC EDGAR, amendments applied. Long US positions only; not a recommendation.